The Novel Coronavirus 2019, was first reported on in Wuhan, China in late December 2019.  The outbreak was declared a public health emergency of international concern in January 2020 and on March 11th, 2020, the outbreak was declared a global pandemic.  The spread of this virus is now global with lots of media attention.  The virus has been named SARS-CoV-2 and the disease it causes has become known as coronavirus disease 2019 (COVID-19). This new outbreak has been producing lots of hysteria and false truths being spread, however the data surrounding the biology, epidemiology, and clinical characteristics are growing daily, making this a moving target.

REBEL COVID-19

will serve as a summary of what is currently known, how to screen, when to test, and how to prevent spread, and any new data/information on COVID-19.

  • All Categories
  • Cardiovascular
  • Endocrine, Metabolic, Fluid, and Electrolytes
  • Hematology and Oncology
  • Infectious Disease
  • Neurology
  • Pediatrics
  • Procedures and Skills
  • Resuscitation
  • Thoracic and Respiratory
All Categories
  • All Categories
  • Cardiovascular
  • Endocrine, Metabolic, Fluid, and Electrolytes
  • Hematology and Oncology
  • Infectious Disease
  • Neurology
  • Pediatrics
  • Procedures and Skills
  • Resuscitation
  • Thoracic and Respiratory

COVID-19 Update: Aerosol Box, Awake Proning, Prediction Scores, & Doing the Basics Right

While the rate of prepublications on COVID19 continue to be cranked out, we at REBEL EM have reduced our blog post production. It’s not because we’re reading less, but  we’ve reported enough on small, retrospective, observational studies that don’t tell ...

Read More
Infectious DiseaseThoracic and Respiratory

COVID-19 Acute Lung Injury: A Proposed Model (v1.0) via Farid Jalali, MD

There is a lot we still do not know when it comes to COVID-19 pathophysiology. We are learning every day, and as we navigate the waters of the unknown, there are a few that boldly dare to try and understand ...

Read More
Thoracic and Respiratory

COVID-19: Triple Antiviral Therapy & IL-1 Inhibition

Background: Current management of COVID-19 focuses on supportive care as there are yet to be robust, data driven treatments. To date, there has barely been a glimmer of hope based on published evidence, as most studies are either poor quality ...

Read More
Infectious Disease

Helmet CPAP vs Venturi Mask in Severe Acute Hypoxemic Respiratory Failure due to Pneumonia

Background: Although Helmet CPAP is not something commonly used in the US, I think its nice to know what other potential options there are to help patients in the midst of a COVID-19 pandemic. Hypoxemic acute respiratory failure (hARF) is a ...

Read More
Thoracic and Respiratory

COVID-19 Cardiovascular Literature Update

There continues to be a slew of publications coming out on a near daily basis in regard to COVID-19.  Some publications will deserve their own posts and others can really be summarized in one or two paragraphs.  In this post ...

Read More
CardiovascularInfectious Disease

COVID-19: Tube Exchange

Introduction: Emergency physicians rarely are involved in tube exchanges; I can’t remember the last time I had to do one. However, during the COVID19 surge, we found ourselves boarding intubated patients for days and even weeks as our ICUs were ...

Read More
Resuscitation

COVID-19: Neurologic Manifestations

The Novel Coronavirus 2019, was first reported on in Wuhan, China in late December 2019.  The outbreak was declared a public health emergency of international concern in January 2020 and on March 11th, 2020, the outbreak was declared a global ...

Read More
Infectious DiseaseNeurology

COVID-19 NIV: Helmet vs Mask

Background: Over the past few weeks there has been a shift in the management of critically ill COVID-19 patients.  Many seem to have moved away from an intubate early strategy to the use of high flow nasal cannula (HFNC) and ...

Read More
Thoracic and Respiratory

COVID-19: Two More Trials Just Published on Remdesivir

Background: Currently, there are no approved medications for the treatment of COVID-19, but,  there are many investigational agents that have shown antiviral activity against SARS-CoV-2 in vitro.  Unfortunately in vitro studies do not always extrapolate to clinical care  In vitro ...

Read More
Infectious Disease

COVID-19: Home O2 Protocol

Needs Assessment: As the COVID19 pandemic continues to mount, hospitals will rapidly reach maximal capacity. As a result, patients are boarding longer in the ED and, new patients are waiting longer to be seen. This dynamic poses numerous threats to ...

Read More
Thoracic and Respiratory

Sponsored